|Test||HIV-1 RNA VIRAL LOAD, PLASMA|
|Methodology||COBAS Ampliprep/COBAS Taqman HIV-1 Test, version 2.0 (Quantitative RT-PCR)|
|Description||Useful for quantification of HIV in plasma (viral load), for monitoring drug therapy and disease progression from known HIV-1 infected patients with or without anti-HIV therapy
This test should not be used as a primary screening or diagnostic test.
NOTE: HIV testing is not available for specimens originating in New York.
NOTE: This test, when ordered on Medicare patients, is subject to the National Coverage Determination (NCD) policy "Human Immunodeficiency Virus (HIV) Testing (Prognosis Including Monitoring)". Please verify that the diagnosis code (ICD-9) you have chosen demonstrates medical necessity for the test as documented in the physician's patient record. The CMS web site or the NorDx Medical Necessity Reference Guide are available to assist you with this verification. A properly executed Advance Beneficiary Notice (ABN) must be submitted with the specimen if medical necessity is not demonstrated by the ICD-9 code chosen or if the frequency of a frequency-limited test is unknown.
|Specimen||Draw blood in a lavender-top (EDTA) tube. Spin down, remove plasma from cells within 24 hours, and send 2.0 mL of EDTA plasma FROZEN in a screw-capped plastic vial.|
HIV-1 RNA quantitative range is 20-10,000,000 copies/mL
|Analytic Time||1 Day; Maximum Laboratory Time - 8 Days|
|Day(s) Test Set Up||Thursday|